Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.

Scott S TykodiLucio N GordanRobert S AlterEdward ArrowsmithMichael R HarrisonIvor PercentRakesh SingalPeter Van VeldhuizenDaniel J GeorgeThomas HutsonJoshua ZhangJesus ZocoJennifer L JohansenArash Rezazadeh Kalebasty

Published in: Journal for immunotherapy of cancer (2022)

NCT02982954.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
open label